Results 21 to 30 of about 2,809,929 (262)

Ventricular tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy: How to Manage? [PDF]

open access: yesClinical and Research Journal in Internal Medicine, 2022
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a condition characterized by fibrofatty replacement of the RV myocardium due to genetic abnormality.
diah ivana, Cholid Tri Tjahjono
doaj   +2 more sources

Genetics of arrhythmogenic right ventricular cardiomyopathy

open access: yesCurrent Opinion in Cardiology, 2002
Recent advances in molecular genetics of arrhythmogenic right ventricular cardiomyopathy (ARVD) are reviewed. In particular, the finding of mutations in the gene coding for cardiac ryanodine receptor (hRYR2), both in patients affected with ARVD2 and in patients affected with catecholaminergic ventricular arrhythmias or with familial ventricular ...
DANIELI, GIAN ANTONIO   +1 more
openaire   +4 more sources

Arrhythmogenic right ventricular cardiomyopathy. [PDF]

open access: yesEur Heart J
Abstract Arrhythmogenic cardiomyopathy (ACM) is a form of inheritable cardiomyopathy characterized by ventricular scarring and/or fibro-fatty replacement. ACM is associated with a significant risk of sudden cardiac death due to ventricular arrhythmias, especially in young patients and endurance athletes.
Gasperetti A   +4 more
europepmc   +3 more sources

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

open access: yesIndian Pacing and Electrophysiology Journal, 2003
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is characterized by the patchy replacement of myocardium by fatty or fibrofatty tissue.
Julia H. Indik, Frank I. Marcus
doaj   +2 more sources

Atrial tachycardia in a patient with arrhythmogenic right ventricular cardiomyopathy/dysplasia

open access: yesJournal of Arrhythmia, 2013
We describe a 49-year-old woman with atrial tachycardia (AT) and arrhythmogenic right ventricular cardiomyopathy/dysplasia. Cardiac magnetic resonance images showed a markedly dilated right atrium and right ventricle.
Hiroaki Mano   +11 more
doaj   +2 more sources

Reversible methamphetamine-induced cardiomyopathy mimicking arrhythmogenic right ventricular cardiomyopathy with ventricular tachycardia

open access: yesHeartRhythm Case Reports, 2020
Among numerous etiologies of ventricular arrhythmias, arrhythmogenic right ventricular cardiomyopathy (ARVC) and methamphetamine-induced cardiomyopathy (MAC) are 2 of the rarer causes of ventricular arrhythmias.1 ARVC is a disease that is characterized ...
Aidan (Jia Sheng) Yu, MBBS   +3 more
doaj   +2 more sources

Multimodality imaging in arrhythmogenic cardiomyopathy [PDF]

open access: yesRomanian Journal of Cardiology, 2021
Arrhythmogenic cardiomyopathy, as it has been recently redefined, is characterized by progressive myocyte loss with fibrosis and fat infiltration of the myocardium, which finally leads to a broad clinical spectrum ranging from heart failure symptoms to ...
Laura Tapoi   +3 more
doaj   +1 more source

Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics

open access: yesNature Cardiovascular Research, 2023
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a fatal genetic heart disease characterized by cardiac arrhythmias, in which fibrofatty deposition leads to heart failure, with no effective treatments. Plakophilin 2 (PKP2) is the most frequently
W. Bradford   +12 more
semanticscholar   +1 more source

AAV-mediated Delivery of Plakophilin-2a Arrests Progression of Arrhythmogenic Right Ventricular Cardiomyopathy in Murine Hearts: Preclinical Evidence Supporting Gene Therapy in Humans

open access: yesbioRxiv, 2023
Background Pathogenic variants in plakophilin-2 (PKP2) cause arrhythmogenic right ventricular cardiomyopathy (ARVC), a disease characterized by life-threatening arrhythmias and progressive cardiomyopathy leading to heart failure.
C. V. van Opbergen   +13 more
semanticscholar   +1 more source

Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy.

open access: yesJournal of the American College of Cardiology, 2023
BACKGROUND Clinical guidelines recommend regular screening for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources.
S. Muller   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy